Biotech Firm Omega Therapeutics Gets OK For Ch. 11 Plan
By Rick Archer · July 30, 2025, 2:27 PM EDT
A Delaware bankruptcy judge approved biotechnology developer Omega Therapeutics' Chapter 11 plan Wednesday, after no objections to the company's plan to distribute its remaining assets were raised at a brief hearing....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login